Opioid toxicity: Difference between revisions
Ostermayer (talk | contribs) |
Ostermayer (talk | contribs) |
||
| Line 40: | Line 40: | ||
===[[Naloxone]] (Narcan)=== | ===[[Naloxone]] (Narcan)=== | ||
''May repeat [[Naloxone]] q3min up to max dose 10mg. It has an almost immediate onset of action with a duration of action = 20-90min (depending on the drug ingested, most overdoses especially from heroin will require repeat dosing of Naloxone) | ''May repeat [[Naloxone]] q3min up to max dose 10mg. It has an almost immediate onset of action with a duration of action = 20-90min (depending on the drug ingested, most overdoses especially from heroin will require repeat dosing of Naloxone) | ||
====Dosing=== | ====Dosing==== | ||
*If apneic or near-apneic - 2mg IV | *If apneic or near-apneic - 2mg IV | ||
*If opioid-naive with minimal respiratory depression - 0.4mg IV | *If opioid-naive with minimal respiratory depression - 0.4mg IV | ||
Revision as of 01:05, 13 April 2015
Background
- Obtain acetaminophin levels in all cases of combination opioid-acetaminophen overdoses
- Respiratory depression is the cause of all mortality from opioid toxicity
- When prescribing opioid pain relievers in the ED, remember to have a discussion of co-ingestion of other depressants (alcohol involved in 1/5 of opioid related deaths)[1]
- Consider contributing to the DAWN database for public ED research benefit (Drug Abuse Warning Network)
- Other than common co-ingestions, consider adulterants such as amphetamines, anticholinergics, hypnotics, heavy metals, etc.
Clinical Features
Common
- Miosis
- N/V
- Respiratory depression
- Mental status depression
Uncommon
- QT prolongation (methadone)
- Seizure (tramadol)
- Acute lung injury
- Bowel obstruction, rupture (body packers)
- Noncardiogenic pulmonary edema (1-2% of heroin overdoses)[2]
- Within 2-4 hrs of overdose
- Increased RR, cough, pink frothy sputum, CXR with b/l infiltrates
- Resolves in 24-48 hrs with respiratory supportive care
Differential Diagnosis
- Clonidine toxicity
- Organophosphate toxicity
- CO poisoning
- Hypoglycemia
- Postictal state
- CVA - pontine hemorrhage (miosis, coma)
- ARDS
- DKA, hyperosmolar coma
Sedative/hypnotic toxicity
- Absinthe
- Barbiturates
- Benzodiazepines
- Chloral hydrate
- Gamma hydroxybutyrate (GHB)
- Baclofen toxicity
- Opioids
- Toxic alcohols
- Xylazine toxicity
- Phencyclidine toxicity
- Phenothiazine toxicity
Treatment
Airway protection and ventilatory management
- BVM and naloxone administration may prevent need for intubation
Naloxone (Narcan)
May repeat Naloxone q3min up to max dose 10mg. It has an almost immediate onset of action with a duration of action = 20-90min (depending on the drug ingested, most overdoses especially from heroin will require repeat dosing of Naloxone)
Dosing
- If apneic or near-apneic - 2mg IV
- If opioid-naive with minimal respiratory depression - 0.4mg IV
- If opioid-dependent with minimal respiratory depression - 0.05mg IV
- Infusion
- Only give if the patient responded to the bolus and required repeat administration
- Step 1: Determine the "wake-up dose" or bolus required to wake the pt
- Step 2: Give 2/3 of the "wake-up dose" per hr; mix in 1L D5W
GI decontamination
- Activated charcoal x1 if opioid ingestion occurred within 1hr
Disposition
- Heroin intoxication:
- Consider discharge 1-2hr after naloxone administration if all are true:
- Independent mobility
- O2 sat >92% (room air)
- RR >10bpm
- HR >50
- Normal temp
- GCS 15
- Consider discharge 1-2hr after naloxone administration if all are true:
- Non-heroin intoxication:
- Consider discharge after 4-6hr obs
- Consider discharge with Rx for Naloxone
- Naloxone 2 mg/2 mL prefilled syringe and intranasal atomizer device
#2 each
Spray one-half of syringe (1 mL) into each nostril upon signs of opioid overdose. May repeat X 1. Call 911.
- Naloxone 2 mg/2 mL prefilled syringe and intranasal atomizer device
See Also
External Links
Source
- ↑ Jones CM, Paulozzi LJ, Mack KA. Alcohol Involvement in Opioid Pain Reliever and Benzodiazepine Drug Abuse–Related Emergency Department Visits and Drug-Related Deaths — United States, 2010. CDC MMWR. October 10, 2014 / 63(40);881-885.
- ↑ Sporer KA and Dorn E. Heroin-related noncardiogenic pulmonary edema: a case series. Chest. 2001; 120(5):1628-32.
